Takeda (TSE:4502/NYSE:TAK) and Protagonist Therapeutics, Inc. (“Protagonist”) (NASDAQ:PTGX) today announced that the U.S. Food and Drug Administration (FDA) accepted the New Drug Application (NDA) and ...
Kindergarteners at the game station run by Valley High School junior Roman D’Argan rushed to find rhyming words on signs sprawled across the floor Monday at Martin Elementary School. D’Argan remembers ...
Sign up for the Slatest to get the most insightful analysis, criticism, and advice out there, delivered to your inbox daily.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results